Actively Recruiting

Phase Not Applicable
Age: 18Years - 80Years
All Genders
ID06767137

Comparative Efficacy of Bedtime Restriction Therapy and Cognitive Behavioral Therapy for Insomnia - a Randomized Controlled Non-inferiority Trial

Led by Christoph Nissen · Updated on 2025-02-17

160

Participants Needed

2

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating two behavioral treatments for adults with insomnia disorder: Bedtime Restriction Therapy (BRT) and Cognitive Behavioral Therapy for Insomnia (CBT-I). The study aims to compare these therapies to determine if the simpler BRT is as effective as CBT-I in improving insomnia symptoms. Both treatments teach techniques to better manage sleep schedules and habits to help improve sleep quality. CBT-I involves six 90-minute group sessions over six weeks and includes sleep education, bedtime restriction, stimulus control, cognitive therapy, and relaxation techniques. BRT is a shorter, simpler therapy with four 60-minute group sessions over six weeks, focusing only on aligning time in bed with actual sleep duration through individualized sleep windows and group discussions to support participants. Participants will attend therapy sessions and complete assessments at the start and at 6 weeks, 3 months, and 6 months to monitor changes in insomnia severity using the Insomnia Severity Index (ISI). The study also monitors participant adherence and overall clinical symptom improvement during these periods. Total participation spans at least six months with regular evaluations to assess outcomes and treatment effects.

CONDITIONS

Brief Title

Comparative Efficacy of BRT and CBT-I for Insomnia

Who Can Participate

Age: 18Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Must meet DSM-5 criteria for insomnia disorder
  • Adults aged 18 to 80 years
  • Capable of giving written informed consent
  • Sufficient fluency in the study site's language (German or French) to understand all study-related information
Not Eligible

You will not qualify if you...

  • Unstable, progressive, or degenerative medical condition
  • Acute pain or poorly managed chronic pain
  • Suicidality
  • Uncontrolled psychiatric condition requiring treatment outside of study
  • Alcohol or drug abuse or dependency
  • Diagnosis of psychosis, bipolar disorder, autism, borderline personality disorder, or antisocial personality disorder
  • Clinical evidence of sleep disorders other than insomnia (e.g., sleep apnea, restless legs, periodic limb movements in sleep, parasomnia)
  • Evidence of intellectual disability
  • Regular intake of benzodiazepines (BZD) or benzodiazepine receptor agonists (BZDRA)
  • Alteration of medication within 4 weeks prior to study treatment or planned alteration during the trial period (stable medication except BZD or BZDRA does not lead to exclusion)
  • Current other psychotherapy for insomnia
  • Known pregnancy or breastfeeding
  • Inability to comply with study procedure
  • Insufficient fluency in German or French to complete the study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

Outpatient Treatment

Duration - 6 weeks

Participants receive behavioral therapy aimed at improving insomnia symptoms. CBT-I involves six 90-minute group sessions over six weeks including sleep education, bedtime restriction, stimulus control, cognitive therapy, and relaxation techniques. BRT involves four 60-minute group sessions over six weeks focusing on bedtime restriction.

4 to 6 group sessions depending on assigned therapy

Trial Site Locations

Total: 2 locations

1

Universität Bern, Psychotherapeutische Praxisstelle

Bern, Canton of Bern, Switzerland, 3012

Actively Recruiting

2

Service des specialités psychiatriques, Hôpitaux universitaires de Genève

Geneva, Canton of Geneva, Switzerland, 1201

Actively Recruiting

Loading map...

Research Team

E

Elisabeth Hertenstein, PD, PhD

M

Marie Angelillo, MSc

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here